Unusual reduction of the in vitro skin permeation of [3H]dexetimide by atropine

Pharmaceutical Research

Volumn 15, Issue 1, 1998, Pages 145-148

  Bosman, Ingrid J ^a,b   Ensing, Kees ^c   De Zeeuw, Rokus A ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NONE

Author keywords

3H dexetimide; Anticholinergics; Atropine; In vitro permeation; Transdermal delivery

Indexed keywords

ATROPINE; BENZATROPINE MESILATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; LAUROCAPRAM; OXYPHENCYCLIMINE; SCOPOLAMINE BROMIDE; SILASTIC; SILICONE; TRITIUM; TROPICAMIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SOLUTION; EPIDERMIS; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; SKIN PERMEABILITY; SWINE;

ADJUVANTS, ANESTHESIA; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIPARKINSON AGENTS; ATROPINE; CELL MEMBRANE PERMEABILITY; DEUTERIUM; DEXETIMIDE; DRUG INTERACTIONS; MEMBRANES; RADIOPHARMACEUTICALS; SKIN; SWINE;

EID: 0031939291     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011977509931     Document Type: Article

References (15)

1. R. H. Guy and J. Hadgraft. Pharmacy International 5:112-116 (1986).
2. I. J. Bosman. Standardization procedure for the in vitro permeation of anticholinergics. In thesis, ISBN 90-3670639-4, Transdermal delivery of anticholinergic bronchodilators. Methodological and clinical aspects, FEBO Druk B.V., Enschede, The Netherlands, 1996, pp. 23-53.
3. I. P. Dick and R. C. Scott. J. Pharm. Pharmacol. 44:640-645 (1992).
4. R. L. Bronaugh, R. F. Stewart, and E. R. Congdon. Toxicol. Appl. Pharmacol. 62:481-488 (1982).
5. A. S. Bhatti, R. C. Scott, and A. Dyer. J. Pharm. Pharmacol. 40(Suppl.):45P (1988).
6. B. W. Barry. Methods for studying percutaneous absorption. In Dermatological Formulations: Percutaneous absorption. Marcel Dekker, New York, 1983, pp. 234-295.
7. E. W. Smith and J. M. Haigh. Acta Pharm. Nord. 4:171-178 (1992).
8. P. J. Swart, W. L. Weide, and R. A. de Zeeuw. Int. J. Pharm. 87:67-72 (1992).
9. K. Ensing, I. J. Bosman, A. C. G. Egberts, J. P. Franke, and R. A. de Zeeuw. J. Pharm. Biomed. Anal. 12:53-58 (1994).
10. S. W. Frantz. Instrumentation and methodology for in vitro skin diffusion cells in methodology for skin absorption. In B. W. Kemppainen and W. G. Reifenrath (eds.), Methods for Skin Absorption, CRC Press, Florida, 1990, pp. 35-59.
11. P. J. Munson and D. Rodbard. Anal. Biochem. 107:220-239 (1980).
12. B. W. Hadzija, S. B. Ruddy, and E. Scott Ballenger. J. Pharm. Pharmacol. 44:387-390 (1992).
13. L. W. D. Weber. Toxicology 84:125-140 (1993).
14. J. W. Wiechers. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbl. Sci. Ed. 11:185-198 (1989).
15. C. R. Behl, S. Kumar, A. W. Malick, S. B. Patel, H. Char, and D. Piemontese. Choice of membranes for in vitro skin uptake studies and general experimental techniques. In B.W. Kemppainen and W.G. Reifenrath (eds.), Methods for Skin Absorption, CRC Press, Florida, 1990, pp. 1-21.